{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T09:11:24Z","timestamp":1764753084725,"version":"3.46.0"},"reference-count":36,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T00:00:00Z","timestamp":1764720000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:p>Head and neck cancer (HNC) remains a pressing global health challenge, particularly in regions with lower socioeconomic status, where risk behaviors such as tobacco use and alcohol consumption are prevalent. Despite advances in treatment, reliable biomarkers for the early detection and monitoring of HNC remain lacking. The \u03b1-Gal carbohydrate epitope, absent in humans but present in other mammals, has garnered interest due to the natural presence of anti-\u03b1-Gal antibodies in the human immune repertoire, comprising approximately 1% of total circulating IgG. We investigated the role of anti-\u03b1-Gal IgG as a potential biomarker by performing ELISA on serum samples from a cohort of 11 patients diagnosed with squamous cell carcinoma (SCC) of the head and neck. Eight were older male patients, most of whom lived in rural areas and engaged in manual occupations. High rates of tobacco (81.8%) and alcohol consumption (63.6%) were observed, in line with established risk factors for HNC. These individuals showed significantly elevated anti-\u03b1-Gal antibody titers compared to non-cancer controls. Chemotherapy with cisplatin did not markedly affect antibody levels, suggesting consistent immune reactivity across treatment status. These results suggest that anti-\u03b1-Gal antibodies may serve as promising biomarker candidates in HNC and warrant further investigation to clarify their potential diagnostic and immunotherapeutic applications.<\/jats:p>","DOI":"10.3389\/fonc.2025.1686122","type":"journal-article","created":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T09:07:53Z","timestamp":1764752873000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Sociodemographic determinants and assessment of anti-\u03b1-Gal IgG titers in head and neck cancer patients"],"prefix":"10.3389","volume":"15","author":[{"given":"Dayse Marcielle de Souza","family":"Lopes","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clarissa Fernandes","family":"Gomes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina Paix\u00e3o","family":"Dur\u00e3es","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Larissa Lopes","family":"Fonseca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah Patr\u00edcia Souza","family":"Costa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andr\u00e9 Luiz Sena","family":"Guimar\u00e3es","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S\u00f4nia Ribeiro","family":"Arrudas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guilherme Ara\u00fajo","family":"Lacerda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. G.","family":"Finn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S\u00edlvio Fernando Guimar\u00e3es","family":"de Carvalho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana Paula Venuto","family":"Moura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandre Ferreira","family":"Marques","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,12,3]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3390\/medsci11020042","article-title":"Epidemiology, risk factors, and prevention of head and neck squamous cell carcinoma","volume":"11","author":"Barsouk","year":"2023","journal-title":"Med Sci (Basel)"},{"key":"B2","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/s41572-020-00224-3","article-title":"Head and neck squamous cell carcinoma","volume":"6","author":"Johnson","year":"2020","journal-title":"Nat Rev Dis Prim"},{"key":"B3","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.oraloncology.2014.01.016","article-title":"International trends in head and neck cancer incidence rates: differences by country, sex and anatomic site","volume":"50","author":"Simard","year":"2014","journal-title":"Oral Oncol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3390\/oral1040031","article-title":"Social determinants of health-related quality of life outcomes for head and neck cancer patients","volume":"1","year":"2021","journal-title":"Oral"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1007\/s12070-019-01683-1","article-title":"Biomarkers in head and neck cancer an update","volume":"71","author":"Basheeth","year":"2019","journal-title":"Indian J Otolaryngol Head Neck Surg"},{"key":"B6","doi-asserted-by":"publisher","first-page":"e209","DOI":"10.1002\/ctm2.209","article-title":"Head and neck cancer: Emerging concepts in biomarker discovery and opportunities for clinical translation","volume":"10","author":"Kowalski","year":"2020","journal-title":"Clin Transl Med"},{"key":"B7","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1016\/j.surg.2005.09.030","article-title":"MUC1 plays a role in tumor maintenance in aggressive thyroid carcinomas","volume":"138","author":"Patel","year":"2005","journal-title":"Surgery"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-12-2940","article-title":"Increased circulation of galectin-3 in cancer induces secretion of metastasis-promoting cytokines from blood vascular endothelium","volume":"19","author":"Chen","year":"2013","journal-title":"Clin Cancer Res"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19020430","article-title":"Role of galectins in tumors and in clinical immunotherapy","volume":"19","author":"Chou","year":"2018","journal-title":"Int J Mol Sci"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.4240\/wjgs.v12.i12.468","article-title":"Carbohydrate antigen 19-9 - tumor marker: Past, present, and future","volume":"12","author":"Lee","year":"2020","journal-title":"World J Gastrointest Surg"},{"key":"B11","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1038\/s41392-024-01823-2","article-title":"Tumor biomarkers for diagnosis, prognosis and targeted therapy","volume":"9","author":"Zhou","year":"2024","journal-title":"Signal Transduct Targeted Ther"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1093\/glycob\/cww065","article-title":"Interactions of mucins with the Tn or Sialyl Tn cancer antigens including MUC1 are due to GalNAc-GalNAc interactions","volume":"26","author":"Haugstad","year":"2016","journal-title":"Glycobiology"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2020.08.032","article-title":"Amplifying immunogenicity of prospective Covid-19 vaccines by glycoengineering the coronavirus glycan-shield to present alpha-gal epitopes","volume":"38","author":"Galili","year":"2020","journal-title":"Vaccine"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/0167-5699(93)90261-I","article-title":"Interaction of the natural anti-Gal antibody with alpha-galactosyl epitopes: a major obstacle for xenotransplantation in humans","volume":"14","author":"Galili","year":"1993","journal-title":"Immunol Today"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1711.2005.01366.x","article-title":"The alpha-gal epitope and the anti-Gal antibody in xenotransplantation and in cancer immunotherapy","volume":"83","author":"Galili","year":"2005","journal-title":"Immunol Cell Biol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2024.12.010","article-title":"Hyperacute rejection-engineered oncolytic virus for interventional clinical trial in refractory cancer patients","author":"Zhong","year":"2025","journal-title":"Cell"},{"key":"B17","article-title":"Cancer immunotherapy by intratumoral injection of alpha-gal glycolipids","volume":"32","author":"Whalen","year":"2012","journal-title":"Anticancer Res"},{"key":"B18","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1186\/s12935-019-1059-8","article-title":"AGI-134: a fully synthetic alpha-Gal glycolipid that converts tumors into in situ autologous vaccines, induces anti-tumor immunity and is synergistic with an anti-PD-1 antibody in mouse melanoma models","volume":"19","author":"Shaw","year":"2019","journal-title":"Cancer Cell Int"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.172380699","article-title":"Glycosylation defining cancer Malignancy: new wine in an old bottle","volume":"99","author":"Hakomori","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1038\/nrc3982","article-title":"Glycosylation in cancer: mechanisms and clinical implications","volume":"15","author":"Pinho","year":"2015","journal-title":"Nat Rev Can"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1021\/acsinfecdis.6b00114","article-title":"Virus-like particle display of the alpha-gal epitope for the diagnostic assessment of chagas disease","volume":"2","author":"Brito","year":"2016","journal-title":"ACS Infect Dis"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1017\/S0031182018000860","article-title":"Anti-alpha-Gal antibodies detected by novel neoglycoproteins as a diagnostic tool for Old World cutaneous leishmaniasis caused by Leishmania major","volume":"145","author":"Subramaniam","year":"2018","journal-title":"Parasitology"},{"key":"B23","doi-asserted-by":"publisher","first-page":"4230","DOI":"10.1038\/s41598-025-88684-z","article-title":"Socio-demographic disparities in global trends of lip and oral cavity neoplasms from 1990 to 2021","volume":"15","author":"Ghanem","year":"2025","journal-title":"Sci Rep"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.lana.2024.100986","article-title":"Disparities in stage at diagnosis of head and neck tumours in Brazil: a comprehensive analysis of hospital-based cancer registries","volume":"42","author":"Nascimento de Carvalho","year":"2025","journal-title":"Lancet Region Health \u2013 Am"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.31416","article-title":"Tobacco smoking and alcohol drinking at diagnosis of head and neck cancer and all-cause mortality: Results from head and neck 5000, a prospective observational cohort of people with head and neck cancer","volume":"143","author":"Beynon","year":"2018","journal-title":"Int J Can"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.14740\/wjon1104w","article-title":"Major risk factors in head and neck cancer: A retrospective analysis of 12-year experiences","volume":"9","author":"Dhull","year":"2018","journal-title":"World J Oncol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/s44276-024-00089-z","article-title":"Head and neck cancer incidence is rising but the sociodemographic profile is unchanging: a population epidemiological study (2001\u20132020)","volume":"2","author":"Smith","year":"2024","journal-title":"BJC Rep"},{"key":"B28","article-title":"Gender differences in smoking and risk for oral cancer","volume":"56","author":"Muscat","year":"1996","journal-title":"Cancer Res"},{"key":"B29","doi-asserted-by":"publisher","first-page":"102319","DOI":"10.1016\/j.canep.2022.102319","article-title":"Differences in risk factors for head and neck cancer among men and women in Nepal: A case-control study","volume":"82","author":"Shrestha","year":"2023","journal-title":"Cancer Epidemiol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1101\/gad.314849.118","article-title":"Molecular mechanisms of the preventable causes of cancer in the United States","volume":"32","author":"Golemis","year":"2018","journal-title":"Genes Dev"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph17218089","article-title":"Impact of gene-environment interactions on cancer development","volume":"17","author":"Mbemi","year":"2020","journal-title":"Int J Environ Res Public Health"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines8020285","article-title":"Gut microbiota abrogates anti-alpha-gal igA response in lungs and protects against experimental aspergillus infection in poultry","volume":"8","author":"Mateos-Hernandez","year":"2020","journal-title":"Vaccines (Basel)"},{"key":"B33","article-title":"The natural anti-Gal antibody, the B-like antigen, and human red cell aging","volume":"14","author":"Galili","year":"1988","journal-title":"Blood Cells"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-009-0662-2","article-title":"Intratumoral injection of alpha-gal glycolipids induces a protective anti-tumor T cell response which overcomes Treg activity","volume":"58","author":"Abdel-Motal","year":"2009","journal-title":"Cancer Immunol Immunother"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics16101263","article-title":"Self-Tumor Antigens in Solid Tumors Turned into Vaccines by alpha-gal Micelle Immunotherapy","volume":"16","author":"Galili","year":"2024","journal-title":"Pharmaceutics"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.178.7.4676","article-title":"Intratumoral injection of alpha-gal glycolipids induces xenograft-like destruction and conversion of lesions into endogenous vaccines","volume":"178","author":"Galili","year":"2007","journal-title":"J Immunol"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2025.1686122\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T09:07:53Z","timestamp":1764752873000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2025.1686122\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,3]]},"references-count":36,"alternative-id":["10.3389\/fonc.2025.1686122"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2025.1686122","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,3]]},"article-number":"1686122"}}